| Primary |
| Drug Use For Unknown Indication |
35.7% |
| International Normalised Ratio Increased |
14.3% |
| Product Used For Unknown Indication |
14.3% |
| Abdominal Pain |
7.1% |
| Blood Thromboplastin Increased |
7.1% |
| Lung Disorder |
7.1% |
| Prophylaxis |
7.1% |
| Vitamin Supplementation |
7.1% |
|
| Haemorrhage Intracranial |
30.8% |
| Medication Error |
23.1% |
| Generalised Erythema |
7.7% |
| Jaundice |
7.7% |
| Post Procedural Haemorrhage |
7.7% |
| Rash Erythematous |
7.7% |
| Tremor |
7.7% |
| Unresponsive To Stimuli |
7.7% |
|
| Secondary |
| Product Used For Unknown Indication |
25.6% |
| Drug Use For Unknown Indication |
18.3% |
| Pneumonia Aspiration |
9.8% |
| Staphylococcal Bacteraemia |
7.3% |
| Arrhythmia |
3.7% |
| Haemorrhage |
3.7% |
| Prophylaxis |
3.7% |
| Cardiac Failure |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Haemodialysis |
2.4% |
| Hepatitis Cholestatic |
2.4% |
| Hypocalcaemia |
2.4% |
| Lung Disorder |
2.4% |
| Lung Infection |
2.4% |
| Parkinson's Disease |
2.4% |
| Prothrombin Time |
2.4% |
| Staphylococcal Infection |
2.4% |
| Benign Prostatic Hyperplasia |
1.2% |
| Haemorrhage Prophylaxis |
1.2% |
| Hypertension |
1.2% |
|
| Ischaemic Stroke |
13.0% |
| Anaphylactic Shock |
8.7% |
| Dermatitis Exfoliative |
8.7% |
| Urinary Tract Infection Enterococcal |
8.7% |
| Venous Thrombosis |
8.7% |
| Anaphylactoid Shock |
4.3% |
| Hyperthermia |
4.3% |
| Medication Error |
4.3% |
| Monoparesis |
4.3% |
| Overdose |
4.3% |
| Pancytopenia |
4.3% |
| Pruritus |
4.3% |
| Pulmonary Alveolar Haemorrhage |
4.3% |
| Rash Pustular |
4.3% |
| Somnolence |
4.3% |
| Temperature Intolerance |
4.3% |
| Toxic Skin Eruption |
4.3% |
|
| Concomitant |
| Surgery |
19.0% |
| Prophylaxis |
8.2% |
| Nuclear Magnetic Resonance Imaging |
7.3% |
| Drug Use For Unknown Indication |
6.3% |
| Medical Diet |
6.0% |
| Abdominal Pain |
5.9% |
| Product Used For Unknown Indication |
5.8% |
| Chemotherapy |
5.3% |
| Pain |
5.3% |
| Oesophagitis |
4.9% |
| Hypertension |
4.2% |
| Device Related Infection |
2.7% |
| Gastritis Erosive |
2.7% |
| Supraventricular Tachycardia |
2.7% |
| Nuclear Magnetic Resonance Imaging Brain |
2.6% |
| Nausea |
2.5% |
| Gastritis |
2.2% |
| Hypoalbuminaemia |
2.2% |
| Liver Carcinoma Ruptured |
2.2% |
| Hepatic Neoplasm Malignant |
2.0% |
|
| Abdominal Pain |
11.0% |
| Interstitial Lung Disease |
11.0% |
| Rash |
9.6% |
| Skin Plaque |
8.2% |
| Distal Intestinal Obstruction Syndrome |
6.8% |
| Aspartate Aminotransferase Increased |
5.5% |
| Acute Respiratory Distress Syndrome |
4.1% |
| Blood Bilirubin Increased |
4.1% |
| Drug Interaction |
4.1% |
| Rectal Haemorrhage |
4.1% |
| Sepsis |
4.1% |
| Thrombocytopenia |
4.1% |
| Vomiting |
4.1% |
| Cholestasis |
2.7% |
| Deformity |
2.7% |
| Diarrhoea |
2.7% |
| Haematocrit Decreased |
2.7% |
| Hepatic Failure |
2.7% |
| Hypokalaemia |
2.7% |
| Multi-organ Failure |
2.7% |
|
